We are live on ! Find out more
DMTX

Dimension Therapeutics, Inc
DMTX

Delisted

DMTX was delisted on the 6th of November, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of DMTX yet.

DMTX Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q4 2017, worth a combined $0 — down 100% from $109M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of DMTX and 0 opened new positions — a net loss of 34 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was OrbiMed, exiting entirely with an estimated $32.4M sold.

  • 0 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q4 2017, down from 34 in Q3 2017.
  • Funds reported $0 of Dimension Therapeutics, Inc stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Dimension Therapeutics, Inc positions in Q4 2017 and 34 closed out, a net change of -34 holders.
  • The largest Dimension Therapeutics, Inc seller in Q4 2017 was OrbiMed, an estimated $32.4M sold.

Based on aggregated 13F filings for Q4 2017.